Related Experiment Video
Updated: May 8, 2025

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Healthcare professionals challenged by 14 distinct carbapenemase-producing micro-organisms in a war-injured Ukrainian
Nienke L Plantinga1, Suzanne A V van Asten2, Maarten J Schijffelen3
1Laboratory for Medical Microbiology and Public Health (Labmicta), Hengelo, The Netherlands. n.plantinga@antoniusziekenhuis.nl.
Abstract:
The Russia-Ukraine war lead to evacuation of patients across Europe. We present an unprecedented case of a severely injured Ukrainian soldier carrying 11 carbapenemase-producing Enterobacterales, two carbapenemase-producing Pseudomonas aeruginosa and one carbapenem-resistant Acinetobacter baumannii, together harboring six different carbapenemase genes and with evidence for in-patient transfer of resistance plasmids.
More Related Videos
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Published on: April 28, 2017
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: